| 000 | 01736 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516091416.0 | ||
| 264 | 0 | _c20121031 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1538-8514 | ||
| 024 | 7 |
_a10.1158/1535-7163.MCT-12-0068 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aForeman, Pamela K | |
| 245 | 0 | 0 |
_aErbB3 inhibitory surrobodies inhibit tumor cell proliferation in vitro and in vivo. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cJul 2012 |
||
| 300 |
_a1411-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aNeuregulin-1 _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aReceptor, ErbB-3 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 700 | 1 | _aGore, Medini | |
| 700 | 1 | _aKobel, Philip A | |
| 700 | 1 | _aXu, Li | |
| 700 | 1 | _aYee, Helena | |
| 700 | 1 | _aHannum, Charles | |
| 700 | 1 | _aHo, Hoangdung | |
| 700 | 1 | _aWang, Sandra M | |
| 700 | 1 | _aTran, Hieu V | |
| 700 | 1 | _aHorowitz, Michael | |
| 700 | 1 | _aHorowitz, Lawrence | |
| 700 | 1 | _aBhatt, Ramesh R | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 11 _gno. 7 _gp. 1411-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-12-0068 _zAvailable from publisher's website |
| 999 |
_c21750266 _d21750266 |
||